EARLY HUMAN CYTOMEGALOVIRUS INFECTION AND ASSOCIATION WITH ORAL ROTAVIRUS VACCINE IMMUNOGENICITY IN ZAMBIA. 

EARLY HUMAN CYTOMEGALOVIRUS INFECTION AND ASSOCIATION WITH ORAL ROTAVIRUS VACCINE IMMUNOGENICITY IN ZAMBIA. 

Comments are closed.

Facebook
Twitter
YouTube
LinkedIn
Instagram
NGOsource
EVALUATION OF ROTARIX BOOSTER DOSE VACCINATION AT 9 MONTHS FOR SAFETY AND ENHANCED ANTI-ROTAVIRUS IMMUNITY IN ZAMBIAN CHILDREN: A RANDOMISED CONTROLLED TRIAL
September 5, 2024
Human Cytomegalovirus Seropositivity and Its Influence on Oral Rotavirus Vaccine Immunogenicity: A Specific Concern for HIV-Exposed Infants in Low-Income Settings.
September 5, 2024